# Electrode Positions in Cardioverting Atrial Fibrillation

Study · id `cardio:ct-nct03817372` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03817372](<https://clinicaltrials.gov/study/NCT03817372>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03817372

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 468 participants.

## Technical summary

Registry record NCT03817372. Randomized; no masking; primary purpose treatment. Start 2019-02-19 (actual); primary completion 2020-10-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 468 participants (enrolled count; ClinicalTrials.gov record NCT03817372, source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)
- Started: 2019-02-19 (actual) (ClinicalTrials.gov record NCT03817372, source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)
- Primary completion: 2020-10-02 (actual) (ClinicalTrials.gov record NCT03817372, source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)
- Completion: 2020-10-02 (actual) (ClinicalTrials.gov record NCT03817372, source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT03817372, source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03817372-2020-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Electrode Positions in Cardioverting Atrial Fibrillation
- Acronym: EPIC
- Condition: Atrial Fibrillation
- Intervention (Device): Anterior-posterior electrode position
- Intervention (Device): Anterior-lateral electrode position
- Lead sponsor: University of Aarhus
- Lead sponsor class: OTHER
- Collaborator: Regionshospitalet Viborg, Skive
- Collaborator class: OTHER
- Collaborator: Randers Regional Hospital
- Collaborator class: OTHER
- Collaborator: Regionshospitalet Horsens
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University of Aarhus (`cardio:org-university-of-aarhus`)
- Registry lists this organization as a collaborator: Regionshospitalet Viborg, Skive (`cardio:org-regionshospitalet-viborg-skive`)
- Registry lists this organization as a collaborator: Randers Regional Hospital (`cardio:org-randers-regional-hospital`)
- Registry lists this organization as a collaborator: Regionshospitalet Horsens (`cardio:org-regionshospitalet-horsens`)

## Provenance

Content hash: 54a104c7159d8fea3557858dbac47d4d19f351db836764532ad074df4cb71dd7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
